期刊文献+

腹腔镜精准肝切除临床应用价值分析 被引量:32

Clinical Application Value of Laparoscopic Precise Liver Resection
下载PDF
导出
摘要 目的:探讨腹腔镜精准肝切除与开腹常规肝切除治疗原发性肝癌的疗效。方法选取我院2013年5月~2015年5月原发性肝癌70例,按按照入院时间顺序编号,采用随机数字表随机分为对照组(n=35)与观察组(n=35),对照组接受开腹常规肝切除手术,观察组接受腹腔镜精准肝切除手术。比较2组患者手术情况、术后肝功能、并发症和预后等指标。结果观察组与对照组手术时间分别为(102.4±23.1)、(98.3±21.3)min,2组比较无明显差异(t=0.772,P=0.221)。观察组术中出血量(214.6±37.5)ml,明显少于对照组(379.3±45.1)ml(t=-16.612,P=0.000)。观察组住院时间(8.5±2.5) d,明显短于对照组(12.4±3.2)d(t=-5.682,P=0.000)。观察组术后AST(10.5±2.3)U/L,明显低于对照组(15.2±1.9) U/L(t=-9.320,P=0.000);ALT(21.4±2.8)U/L,明显低于对照组(30.2±3.3) U/L(t =-12.030,P=0.000);ALB (56.4±2.4)g/L,高于对照组(42.3±2.0) g/L(t=26.701,P=0.000);TBIL(17.3±1.6)μmol/L,明显高于对照组(15.6±1.1)μmol/L(t=5.180,P=0.000)。观察组并发症发生率5.7%(2/35),明显低于对照组22.9%(8/35,χ^2=4.200,P=0.040)。术后6个月观察组复发转移率3.1%(1/32),对照组转移复发率12.1%(4/33),2组患者转移复发率无明显差异(χ^2=0.801,P=0.371)。2组生存率log-rank检验存在显著差异(χ^2=5.300,P=0.021)。结论腹腔镜精准肝切除治疗原发性肝癌可行,具有创伤小、安全性高等特点,值得临床推广。 Objective To explore the efficacy of laparoscopic precise liver resection and open conventional hepatectomy for the treatment of primary hepatic carcinoma . Methods A total of 70 patients with primary hepatic carcinoma were selected in our hospital from May 2013 to May 2015.All the patients were randomly assigned to either control group (n=35) or observation group (n=35) according to a random number table .The operation condition, liver functions, postoperative complications and other indicators were compared between the two groups . Results The operation time of the observation group and the control group were (102.4 ±23.1) min and (98.3 ±21.3) min, respectively, without significant difference (t=0.772, P=0.221).The amount of bleeding in the observation group was (214.6 ±37.5) ml, which was significantly less than that in the control group [(379.3 ±45.1) ml, t=16.612, P=0.000].The length of hospital stay in the observation group was (8.5 ±2.5) d, which was significantly shorter than that in the control group [(12.4 ±3.2) d, t=-5.682, P=0.000].The postoperative AST level in the observation group was (10.5 ±2.3) U/L, which was lower than that in the control group [(15.2 ±1.9) U/L, t=-9.320, P=0.000].The postoperative ALT level in the observation group [(21.4 ±2.8) U/L] was significantly lower than that in the control group [(30.2 ±3.3) U/L, t=-12.030, P=0.000].The postoperative ALB level in the observation group [(56.4 ±2.4) g/L] was significantly higher than that in the control group [(42.3 ±2.0) g/L, t=26.701, P=0.000].The postoperative TBIL level in the observation group was (17.3 ±1.6) μmol/L, which was significantly higher than that in the control group [(15.6 ±1.1) μmol/L, t=5.180, P=0.000]. The complication rate of the observation group was 5.7%(2/35), significantly lower than that of the control group [22.9%(8/35),χ^2 =4.200, P=0.040).After 6 months after the surgery, the recurrence rate was 3.1%(1/32) in the observation group and was 12.1%(4/33) in the control group, and there was no significant difference in the recurrence rate between the two groups (χ^2 =0.801,P=0.371).The survival rate of the observation group was significantly higher than that of the control group (log-rank χ^2 =5.300, P=0.021). Conclusion Laparoscopic precise hepatectomy for primary liver cancer has high feasibility , low trauma, and high safety, being worthy of clinical application .
出处 《中国微创外科杂志》 CSCD 北大核心 2016年第7期590-593,共4页 Chinese Journal of Minimally Invasive Surgery
关键词 腹腔镜 精准肝切除 原发性肝癌 Laparoscope Precise hepatectomy Primary hepatic carcinoma
  • 相关文献

参考文献14

二级参考文献86

共引文献1200

同被引文献259

引证文献32

二级引证文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部